We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 11-20 of 546

Third Circuit revives shareholder suit over dissolved biotech company
  • Shook Hardy & Bacon LLP
  • USA
  • October 30 2014

A divided Third Circuit Court of Appeals panel has reversed a district court ruling dismissing a shareholder's lawsuit against individuals and a


Nagoya genetic resources protocol enters into force
  • Shook Hardy & Bacon LLP
  • Global, USA
  • October 30 2014

The Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from Their Utilization entered into force


Ninth Circuit okays pharma waste disposal ordinance
  • Shook Hardy & Bacon LLP
  • USA
  • October 30 2014

The Ninth Circuit Court of Appeals has upheld the validity of an Alameda County ordinance that requires prescription drug producers that sell brand


Tech interests praise USPTO director nomination
  • Shook Hardy & Bacon LLP
  • USA
  • October 30 2014

According to a news source, technology industry interests have lauded President Barack Obama's (D) choice for U.S. Patent and Trademark Office


Biotech boards dominated by men
  • Shook Hardy & Bacon LLP
  • USA
  • October 30 2014

A Liftstream analysis reportedly shows that the average Board of Directors in the biotechnology sphere is roughly 90 percent male and more than half


USPTO to host roundtable on harmonization of substantive patent law
  • Shook Hardy & Bacon LLP
  • USA
  • October 2 2014

The U.S. Patent and Trademark Office (USPTO) will host a November 19, 2014, roundtable in Alexandria, Virginia, on the international harmonization of


Non-practicing entity’s suit to halt FTC investigation dismissed
  • Shook Hardy & Bacon LLP
  • USA
  • October 2 2014

A federal court in Texas has dismissed for lack of standing and ripeness and for failure to exhaust administrative remedies a declaratory judgment


Public watchdog calls on FDA to issue “revolving door” guidance
  • Shook Hardy & Bacon LLP
  • USA
  • October 2 2014

Public Citizen recently called on the U.S. Food and Drug Administration (FDA) to take certain steps that would both prohibit the practice of advisory


Shire Pharmaceuticals settles FCA claims for $56.5 million
  • Shook Hardy & Bacon LLP
  • USA
  • October 2 2014

Without admitting liability, Wayne, Pennsylvania-based Shire Pharmaceuticals LLC has entered a settlement agreement with the U.S. Department of


FDA contends Twitter not off limits for pharmaceutical cos.
  • Shook Hardy & Bacon LLP
  • USA
  • October 2 2014

While the U.S. Food and Drug Administration (FDA) has extended the deadline for comments on its draft guidance for drug and medical device makers